N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function-Reference-Cited by-同舟云学术

N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function

Published:2013-02-19 Issue:2 Volume:8 Page:e55701
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pancera Marie,Yang Yongping,Louder Mark K.,Gorman Jason,Lu Gabriel,McLellan Jason S.,Stuckey Jonathan,Zhu Jiang,Burton Dennis R.,Koff Wayne C.,Mascola John R.,Kwong Peter D.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Broad HIV-1 neutralization mediated by CD4-binding site antibodies;Y Li;Nat Med,2007

2. Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection;DN Sather;J Virol,2009

3. Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop;PL Moore;J Virol,2011

4. Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region;ES Gray;J Virol,2009

5. Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables;NA Doria-Rose;J Virol,2010

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative substitutions of N332 in HIV-1 _AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan;mBio;2024-04-10

2. Alternative substitutions of N332 in HIV-1_AD8gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan;2023-11-21

3. ‘Immunization during ART and ATI for HIV-1 vaccine discovery/development’;Current Opinion in HIV and AIDS;2023-09-08

4. Adjuvants influence the maturation of VRC01-like antibodies during immunization;iScience;2022-11

5. Adjuvants influence the maturation of VRC01-like antibodies during immunization;2022-06-13